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osting by EAbstract Matrix metalloproteinases (MMPs), the key enzymes responsible for matrix degradation,
are derived from polymorphonuclear leukocytes during the early stages of periodontitis. The aim of
this study was planned to determine the levels of GCF (gingival crevicular ﬂuid) matrix metallopro-
teinase-8 (MMP-8) and metalloproteinase-9 (MMP-9) patients with periodontitis and in healthy
controls. Levels of crevicular MMP-8 and -9 were determined by ELISA in subjects with healthy
without any periodontal disease (n= 10) and periodontitis (n= 10). Signiﬁcantly higher crevicular
MMP-8 and -9 were observed in cases of periodontitis compared to healthy adults. Crevicular
MMP-8 and -9 may serve as biomarkers of periodontal disease and aid in early detection of peri-
odontitis.
ª 2010 King Saud University. All rights reserved.1. Introduction
Periodontitis is an inﬂammatory disease which affects the sup-
porting tissues of teeth, leading to progressive destruction of
connective tissue attachment and alveolar bone. Matrix
metalloproteinases (MMPs) are the major group of enzymes
responsible for degradation of ECM (extracellular matrix).
The onset of collagen destruction in periodontitis is causedm (B. Rai).
ity. All rights reserved. Peer-
d University.
lsevierby the action of collagenases, a subgroup of MMPs. In the
healthy condition, the periodontal ligament apparatus is
protected from matrix metalloproteinases (MMP)-mediated
proteolytic attack by TIMPs (tissue inhibitors of metallopro-
teinases). In chronic periodontitis, levels of TIMP are low
and thus inadequate to inhibit the elevated MMPs, activated
neutrophil pro-collagenase (pro-MMP-8) and progelatinase
(pro-MMP-9). Furthermore, mobilization and activation of
inﬂammatory cells such as lymphocytes and neutrophils, alter-
ation of immunomodulators and secretion of inﬂammatory
proteases occur (Ingman et al., 1994; Alpagot et al., 2001;
Kinane, 2001; Hutter et al., 2003; Cota et al., 2006). Current
information indicates that bacterial infection may be the
primary causative agent of periodontitis (Alpagot et al.,
2001; Kinane, 2001; Hutter et al., 2003). MMPs-1, 2, 3, 8
and 9 have been found in biopsy specimens of human inﬂam-
matory periodontal tissues, whereas healthy gingiva contains
only pro MMP-2. MMP-2 is secreted by gingival ﬁbroblasts
130 B. Rai et al.and MMP-9 is mainly secreted by polymorphonuclear leuko-
cytes, and they degrade type IV collagen present in gingival
tissues (basement membrane remodeling) (Ingman et al.,
1994; Alpagot et al., 2001; Chang et al., 2000; Kinane, 2001).
The aim of the present study was to compare the levels of
MMP-8 and MMP-9 in gingival crevicular ﬂuid (GCF) from
healthy subjects and periodontitis.
2. Materials and methods
Ten patients with periodontitis (M:F;5:5, aged between 29 and
34 years), and 10 healthy controls (M:F;5:5 aged between 28
and 34 years) were included in this study. Samples were col-
lected and processed at the Jain Diagnostic Centre, New Delhi.
Informed consent was taken from subjects.
2.1. Selection criteria of periodontitis patients
The selection criteria for this group were as follows: At least 18
teeth had to be present, excluding third molars, of which at
least 12 had to be posterior teeth; presence of moderate to ad-
vanced chronic periodontitis (at least 7 teeth with periodontal
pockets deeper than 6 mm); absence of systemic disease; no
history of medication in the previous 5 months and no previ-
ous periodontal treatment. Women who were pregnant or
receiving hormone or vitamin treatment were excluded.
2.2. Selection criteria of healthy
The inclusion criteria were absence of any periodontal disease,
absence of systemic disease; no history of medication in the
previous 5 months and no previous periodontal treatment.
Women who were pregnant or receiving hormone or vitamin
treatment were excluded.
First author recorded the clinical periodontal parameters
(probing pocket depth, bleeding on probing and clinical loss
of attachment) in each subject after the collection of saliva.
Unstimulated saliva was collected from each subject according
to a modiﬁed version of the method described by Navazesh
(2003). Probing depths at six sites per tooth (mesiobuccal, mid-
buccal, distobuccal, mesiolingual, midlingual and distolingual)Table 1 Clinical parameters in subjects (mean ± SD).
Variable Healthy (n
Age (year) (range) 17–56 (32.
Age (year) 34.1 ± 8.7
Number of teeth 20.3 ± 2.2
Probing depth (mm) 2.5 ± 1.9
Clinical loss of attachment (mm) 1.9 ± 0.5
Bleeding on probing (%) 5.32 ± 3.7
No. of teeth with periodontitis 4.12 ± 1.3
Table 2 Mean and standard deviation of crevicular MMP-8 and -9
Variable Healthy (n= 10
Crevicular MMP-8 (pg/ul) 4.13 ± 12.32 (3.
Crevicular MMP-9 (pg/ul) 37.8 ± 24.31 (21
P< 0.05.were measured using a manual probe (Hu-Friedy, Chicago,
USA). Clinical loss of attachment was determined by measur-
ing the interproximal sites only.
One to 4 sites per patient were randomly selected for GCF
collection. The respective tooth was isolated with cotton after
removing the supragingival plaque with curettes (the proce-
dures done on GCF avoiding contamination), and the crevic-
ular area was air-dried. GCF was collected by inserting
Periopaper strips (PerioCol Paper Strips, Oraﬂow Inc., USA)
in gingival pocket for 45s. The strips contaminated by blood
or saliva were discarded. The strips were placed into 50 ll of
0.9% phosphate-buffered saline. After 1 h in ice, the GCF
samples were centrifuged at 9220g for 15 min. In collecting
GCF, the levels of MMP-8 and -9 were measured by En-
zyme-linked immunosorbent assays (R&D systems for
MMP-8, -9 ELISA kit, Minneapolis, MN, USA).
The description of the variables and the correlation of
MMPs with the clinical parameters were analyzed in these pa-
tients using Mann–Whitney and Wilcoxon tests with SPSS ver-
sion 11.0.
3. Results
The control subjects were demographically similar to peri-
odontitis patients (Table 1), but were clearly distinct in terms
of the clinical parameters measured (P< 0.05). The crevicular
MMP-8, -9 levels in periodontitis were higher than those in
healthy subjects (Table 2, P< 0.05).
4. Discussion
MMPs are zinc-dependent endopeptidases derived predomi-
nantly from polymorphonuclear leukocytes during acute stages
of periodontal disease and are the key enzymes responsible for
extracellular collagen matrix degradation (Woessner, 1994;
Delaisse´ et al., 2000; Miller et al., 2006; Rai et al., 2007).
Elevated MMP levels have been observed in inﬂamed human
gingiva and GCF in subjects with adult periodontitis (Villela
et al., 1987; Gangbar et al., 1990; Sorsa et al., 1990). MMP-8
has the unique ability to breakdown type I and III collagen,
which is critical for periodontal destruction. Subantimicrobial= 10) Periodontitis (n= 10)
3) 18–59 (34.5)
36.3 ± 9.6
(18–24) 18.2 ± 3.5 (19–24)
(1.2–4.1) 6.9 ± 1.9 (5.2–7.9)
(1.2–2.4) 5.5 ± 1.3 (3.5–6.9)
1 (3.78–8.56) 57.9 ± 14.6 (44.2–68.8)
2 (3.24–6.89) 10.31 ± 1.32 (9.06–12.08)
in various studies.
) Periodontitis (n= 10)
87–15.96) 15.13 ± 12.46 (11.06–28.36)
.56–68.87) 59.42 ± 22.32 (34.86–78.87)
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disease activity (Caton et al., 2001; Novak et al., 2002). Gingi-
val crevicular MMP-8, -9 levels in periodontitis were higher
than those in healthy subjects. Our results are in agreement
with previous ﬁndings (Ma¨kela¨ et al., 1994; Korostoff et al.,
2000; Maeso et al., 2007).
Further studies may be required to address the role of GCF
MMPs in periodontitis. Also, it remains to be determined
whether the GCF and salivary biomarkers analyzed are capa-
ble of distinguishing health from disease when the nature of
disease is less generalized in subjects. The role of gene poly-
morphism in relation to MMP expression is unclear and so
far, there are no published reports about MMP-8 gene poly-
morphism in periodontal disease. However, there are studies
concerning several cytokine gene polymorphisms associated
with an increased risk of periodontal disease. Increased pro-
duction of a given cytokine is associated with carriage of a risk
genotype. Previously, the risk of having periodontal disease
has been related to carriage of rare alleles of single cytokine
and receptor molecule genes such as IL-1, TNF-a, IL-6 and
CD-14 (Caton et al., 2001; Novak et al., 2002; Miller et al.,
2006; Rai et al., 2007). MMPs are derived predominantly from
polymorphonuclear leukocytes during acute stages of peri-
odontal diseases. Non-neutrophil cells, such as gingival and
periodontal ligament ﬁbroblasts, release MMP-8, whereas
monocytes and macrophages form a potential source of
MMP-9. MMP-2 (gelatinase) is produced by various cells in
the oral cavity, and MMP-9 is found in acinar epithelial cells.
MMPs have been less frequently detected in saliva. However,
recent reports indicated the roles of oral ﬂuid MMP-8 and -9
in periodontitis, as together they can degrade most of extracel-
lular matrix components. Recently, it has been reported that
vivo immune cell interactions in the presence of plasma pro-
teins to show that TC (tetracycline), doxy (doxycycline), and
CMT-3 (chemically modiﬁed tetracycline-3) can reduce the
production of pro-inﬂammatory mediators in periodontitis
(Passoja et al., 2008; Cazalis et al., 2009).
5. Conclusion
Conventional periodontal treatment efﬁciently gave a conclu-
sion that has more impact on reducing the levels of MMP-8
and -9. Hence, MMP-8 and -9 in GCF were studied to study
their correlation with periodontitis. MMP-8, -9 levels in
GCF were higher in patients with chronic periodontitis than
in healthy subjects.
References
Alpagot, T., Bell, C., Lundergan, W., Chambers, D.W., Rudin, R.,
2001. Longitudinal evaluation of GCF MMP-3 and TIMP-1 levels
as prognostic factors for progression of periodontitis. J. Clin.
Periodontol. 28, 353–359.
Caton, J.G., Ciancio, S.G., Blieden, T.M., Bradshaw, M., Crout, R.J.,
Hefti, A.F., Massaro, J.M., Polson, A.M., Thomas, J., Walker, C.,
2001. Subantimicrobial dose doxycycline as an adjunct to scaling
and root planing: post-treatment effects. J. Clin. Periodontol. 8,
782–789.
Cazalis, J., Tanabe, S., Gagnon, G., Sorsa, T., Grenier, D., 2009.
Tetracyclines and chemically modiﬁed tetracycline-3 (CMT-3)
modulate cytokine secretion by lipopolysaccharide-stimulated
whole blood. Inﬂammation 32 (2), 130–137.Chang, Y.C., Yang, S.F., Lai, C.C., Liu, J.Y., Hsieh, Y.S., 2000.
Regulation of matrix metalloproteinase production by cytokines,
pharmacological agents and periodontal pathogens in human
periodontal ligament ﬁbroblast cultures. J. Periodontal Res. 37,
196–203.
Cota, L.O.M., Guimara˜es, A.N., Costa, J.E., Lorentz, T.C.M., Costa,
F.O., 2006. Association between maternal periodontitis and an
increased risk of preeclampsia. J Periodontol 77, 2063–2069.
Delaisse´, J.M., Engsig, M.T., Everts, V., del Carmen Ovejero, M.,
Ferreras, M., Lund, L., Vu, T.H., Werb, Z., Winding, B., Lochter,
A., Karsdal, M.A., Troen, T., Kirkegaard, T., Lenhard, T.,
Heegaard, A.M., Neff, L., Baron, R., Foged, N.T., 2000. Protein-
ases in bone resorption: obvious and less obvious roles. Clin. Chim.
Acta 291, 223–224.
Gangbar, S., Overall, C.M., McCulloch, C.A., Sodek, J., 1990.
Identiﬁcation of polymorphonuclear leukocyte collagenase and
gelatinase activities in mouthrinse samples: correlation with peri-
odontal disease activity in adult and juvenile periodontitis. J.
Periodontal Res. 25, 257–267.
Hutter, G., Schlagenhauf, U., Valenza, G., Horn, M., Burgemeister,
S., Claus, H., Vogel, U., 2003. Molecular analysis of bacteria in
periodontitis: evaluation of clone libraries, novel phylotypes and
putative pathogens. Microbiology 149, 67–75.
Ingman, T., Sorsa, T., Michaelis, J., Konttinen, Y.T., 1994. Matrix
metalloproteinases-1, -3, and -8 in adult periodontitis in situ. An
immunohistochemical study. Ann. NY Acad. Sci. 732, 459–461.
Kinane, D.F., 2001. Causation and pathogenesis of periodontal
disease. Periodontol 25, 8–20.
Korostoff, J.M., Wang, J.F., Sarment, D.P., Stewart, J.C., Feldman,
R.S., Billings, P.C., 2000. Analysis of in situ protease activity in
chronic adult periodontitis patients: expression of activated MMP-
2 and a 40 kDa serine protease. J. Periodontol. 1, 353–360.
Maeso, G., Bravo, M., Bascones, A., 2007. Levels of metalloprotein-
ase-2 and -9 and tissue inhibitor of matrix metalloproteinase-1 in
gingival crevicular ﬂuid of patients with periodontitis, gingivitis,
and healthy gingiva. Quintessence Int. 38, 247–252.
Ma¨kela¨, M., Salo, T., Uitto, V.J., Larjava, H., 1994. Matrix
metalloproteinases (MMP-2 and MMP-9) of the oral cavity:
cellular origin and relationship to periodontal status. J. Dent.
Res. 73, 1397–1406.
Miller, C.S., King Jr., C.P., Langub, M.C., Kryscio, R.J., Thomas,
M.V., 2006. Salivary biomarkers of existing periodontal disease: a
cross-sectional study. J. Am. Dent. Assoc. 137, 322–329.
Navazesh, M., 2003. Methods for collecting saliva. Ann. NY Acad.
Sci. 694, 72–77.
Novak, M.J., Johns, L.P., Miller, R.C., Bradshaw, M.H., 2002.
Adjunctive beneﬁts of subantimicrobial dose doxycycline in the
management of severe, generalized, chronic periodontitis. J. Peri-
odontol. 73, 762–769.
Passoja, A., Ylipalosaari, M., Tervonen, T., Raunio, T., Knuuttila,
M., 2008. Matrix metalloproteinase-8 concentration in shallow
crevices associated with the extent of periodontal disease. J. Clin.
Periodontol. 35 (12), 1027–1031.
Rai, B., Kharb, S., Anand, S.C., 2007. Thiocynate, a salivary marker
of periodontitis among smokers and nonsmokers: a pilot study. J.
Pak. Dent. Assoc. 16, 35–37.
Sorsa, T., Suomalainen, K., Uitto, V.J., 1990. The role of gingival
crevicular ﬂuid and salivary interstitial collagenases in human
periodontal diseases. Arch. Oral Biol. 35 (Suppl.), 193S–196S.
Villela, B., Cogen, R.B., Bartolucci, A.A., Birkedal-Hansen, H., 1987.
Collagenolytic activity in crevicular ﬂuid from patients with
chronic adult periodontitis, localized juvenile periodontitis and
gingivitis, and from healthy control subjects. J. Periodontal Res. 22,
381–389.
Woessner Jr., J.F., 1994. Matrix metalloproteinases and their
inhibitors in connective tissue remodeling. FASEB J. 5,
2145–2154.
